Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease.
Harris KJR, Ludtke EA, Goldberg B, McCall NN, Hewlett JC, Wilfong EM. Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI179-SI183.